FindTrial
Sign In

Chronic paronychia - a form of hand dermatitis

Role of topical corticosteroids and oral antifungals in treatment of chronic paronychia : a randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/07/007107
Enrollment
70
Registered
2016-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic paronychia

Interventions

Intervention1: topical 0.1% betamethasone valerate cream and weekly capsule fluconazole 150 mg: topical 0.1% betamethasone valerate cream applied twice daily over proximal nail fold and weekly capsule

Sponsors

Jawaharlal Institute of Postgraduate Medical Education Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with a clinical diagnosis of chronic paronychia defined as : absence of cuticle with swelling and erythema of proximal nail fold lasting >6 weeks.

Exclusion criteria

Exclusion criteria: 1. Acute paronychia. 2. Chronic paronychia as a part of other dermatological disorders. 3. Patients who are already on topical steroids or oral antifungals in prior 2 weeks. 4. Pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Improvement of chronic paronychiaTimepoint: 9 weeks—

Secondary

MeasureTime frame
Improvement of chroninc paronychiaTimepoint: 3 weeks, 6 weeks;Percentage of patients with positive Candida prick testTimepoint: 0 weeks;Percentage of patients with positive fungal cultureTimepoint: 0 weeks;Percentage of patients with positive patch testTimepoint: 0 weeks—

Countries

India

Contacts

Public ContactD M Thappa

JIPMER

dmthappa@gmail.com9443958975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026